BeStock  
Stocks › Biotechnology › SRRK

Scholar Rock SRRK

US equityMarket cap rank #1884Biotechnology
$48.13 −$2.24 (-4.45%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $48.13 0.00%
Open$49.63
Prev close$50.37
Day range$47.94 – $52.17
Volume2.08M
Market cap$5.87B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$570,000.00
Operating profit-$106.06M-2.4% YoY
Net profit-$107.24M-4.9% YoY
Diluted EPS-$0.81+10.0% YoY
Free cash flow-$81.91M-18.7% YoY
Operating cash flow-$81.81M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$570.0KSep '26

Net profit, last 8 quarters

$-66.5MDec '24$-74.7MMar '25$-110.0MJun '25$-102.2MSep '25$-91.0MDec '25$-105.5MMar '26$-109.9MJun '26$-107.2MSep '26

Diluted EPS by quarter

-0.61Dec '24-0.67Mar '25-0.98Jun '25-0.90Sep '25-0.88Dec '25-0.83Mar '26-0.84Jun '26-0.81Sep '26

Free cash flow by quarter

$-49.5MDec '24$-78.9MMar '25$-77.2MJun '25$-69.0MSep '25$-75.5MDec '25$-82.2MMar '26$-70.3MJun '26$-81.9MSep '26

Annual revenue

$15.4MFY20$18.8MFY21$33.2MFY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Gross margin98.6%
Operating margin-71,732.3%
Net margin-72,563.2%
Return on equity-200.0%
Return on assets-96.4%
Return on invested capital-114.0%
Current ratio5.41
Liabilities / assets62.2%
Cash & investments$413.60M
Total debt$197.17M
Net cash (debt)$216.43M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $570,000.00 – – – –
Total Operating Revenue $570,000.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $8,000.00 – – – –
Gross Profit $562,000.00 – – – –
Operating Expense $106.62M $108.90M $102.02M $384.65M $91.90M
Selling and Admin Expenses $52.50M $50.67M $50.20M $176.21M $45.02M
Research & Development $54.13M $58.23M $51.81M $208.44M $46.88M
Operating Profit -$106.06M -$108.90M -$102.02M -$384.65M -$91.90M
Net Non-Operating Interest Income (Expense) -$538,000.00 -$425,000.00 $633,000.00 $7.01M $992,000.00
Non-Operating Interest Income $4.10M $4.09M $2.94M $13.90M $3.53M
Non-Operating Interest Expense $4.63M $4.52M $2.30M $6.89M $2.53M
Other Income (Expense) -$640,000.00 -$570,000.00 -$4.13M -$301,000.00 -$61,000.00
Special Income (Charges) $0.00 $0.00 -$3.34M – –
Other Non-Operating Income (Expenses) -$640,000.00 -$570,000.00 -$790,000.00 -$301,000.00 -$61,000.00
Pretax Profit -$107.24M -$109.90M -$105.51M -$377.94M -$90.97M
Net Profit -$107.24M -$109.90M -$105.51M -$377.94M -$90.97M
Profit from Continuing Operations -$107.24M -$109.90M -$105.51M -$377.94M -$90.97M
Net Income to Parent Company -$107.24M -$109.90M -$105.51M -$377.94M -$90.97M
Net Income to Common Stockholders -$107.24M -$109.90M -$105.51M -$377.94M -$90.97M
Basic EPS -$0.81 -$0.84 -$0.83 -$3.29 -$0.88
Diluted EPS -$0.81 -$0.84 -$0.83 -$3.29 -$0.88
-General & Admin Expense – $50.67M $50.20M $176.21M $45.02M
-Less:Other Special Charges – – $3.34M – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $445.97M $523.54M $535.25M $404.27M $404.27M
Total Current Assets $433.43M $507.18M $515.28M $385.15M $385.15M
Cash and Cash Equivalents & Short-Term Investments $413.60M $492.09M $479.94M $367.56M $367.56M
-Cash and Cash Equivalents $366.27M $437.09M $430.54M $323.53M $323.53M
-Short Term Investments $47.33M $55.00M $49.40M $44.04M $44.04M
Receivables $2.37M $1.96M $21.48M $2.80M $2.80M
-Accounts Receivable $677,000.00 – – – –
-Other Receivables $1.69M $1.96M $21.48M $2.80M $2.80M
Prepaid Assets $14.28M $13.14M $13.86M $14.79M $14.79M
Inventory $773,000.00 – – – –
Restricted Cash $2.41M – – – –
Total Non-Current Assets $12.54M $16.36M $19.97M $19.13M $19.13M
Net PPE $8.70M $9.79M $11.57M $12.09M $12.09M
-Gross PPE $8.70M $9.79M $11.57M $26.96M $26.96M
Non-Current Prepaid Assets $1.13M $1.45M $3.27M $3.23M $3.23M
Non-Current Deferred Assets $1.32M $1.32M $1.32M – –
Other Non-Current Assets $1.40M $3.81M $3.81M $3.81M $3.81M
Total Liabilities $277.30M $269.76M $259.24M $158.78M $158.78M
Total Current Liabilities $80.12M $72.24M $59.64M $55.42M $55.42M
Payables $6.16M $11.00M $9.22M $10.30M $10.30M
-Accounts Payable $6.16M $11.00M $9.22M $10.30M $10.30M
Current Accrued Expenses $68.14M $54.93M $44.35M $39.57M $39.57M
Short-Term Debt and Capital Lease Obligation $5.82M $6.32M $6.08M $5.55M $5.55M
-Current Capital Lease Obligation $5.82M $6.32M $6.08M $5.55M $5.55M
Total Non-Current Liabilities $197.17M $197.52M $199.60M $103.37M $103.37M
Long Term Debt and Capital Lease Obligation $197.17M $197.52M $199.60M $103.37M $103.37M
-Long Term Debt $196.21M $196.20M $196.61M $99.71M $99.71M
-Long Term Capital Lease Obligation $960,000.00 $1.31M $2.98M $3.66M $3.66M
Total Equity $168.68M $253.78M $276.01M $245.49M $245.49M
Stockholders' Equity $168.68M $253.78M $276.01M $245.49M $245.49M
Capital Stock $122,000.00 $122,000.00 $119,000.00 $108,000.00 $108,000.00
-Common Stock $122,000.00 $122,000.00 $119,000.00 $108,000.00 $108,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.79B $1.77B $1.68B $1.55B $1.55B
Retained Earnings -$1.62B -$1.52B -$1.41B -$1.30B -$1.30B
Gains/Losses Not Affecting Retained Earnings $1.62M $1.14M $690,000.00 $94,000.00 $94,000.00
-Accumulated Depreciation – – – -$14.88M -$14.88M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$81.81M -$70.31M -$82.10M -$300.04M -$75.50M
Net cash flow from continuing operations -$81.81M -$70.31M -$82.10M -$300.04M -$75.50M
Net Income from Continuing Operations -$107.24M -$109.90M -$105.51M -$377.94M -$90.97M
Gain/Loss from Continuing Operations $523,000.00 $1.25M $3.34M – –
Depreciation & Depletion & Amortization $258,000.00 $297,000.00 $335,000.00 $1.66M $425,000.00
Other Non-Cash Items $1.57M $1.63M $1.57M $5.69M $1.48M
Change in Working Capital $5.56M $16.89M $84,000.00 -$1.05M -$5.66M
-Change in Prepaid Assets -$3.28M $4.52M -$2.04M -$3.70M $2.27M
-Change in Payables and Accrued Expense $8.89M $11.97M $3.60M $8.71M -$6.76M
-Change in Other Current Assets $2.73M $1.82M -$37,000.00 -$286,000.00 $86,000.00
-Change in Other Current Liabilities -$1.33M -$1.43M -$1.44M -$5.77M -$1.26M
Net cash flow from investing $7.94M -$5.50M -$5.34M $218.69M $38.97M
Net Cash Flow from Continuing Investing Activities $7.94M -$5.50M -$5.34M $218.69M $38.97M
Net PPE Purchase and Sale -$101,000.00 -$1,000.00 -$68,000.00 -$602,000.00 -$32,000.00
Net Investment Purchase and Sale $8.05M -$5.50M -$5.27M $219.29M $39.00M
Financing Cash Flow $3.13M $83.12M $193.79M $228.40M $73.29M
Net Cash Flow from Continuing Financing Activities $3.13M $83.12M $193.79M $228.40M $73.29M
Net Issuance Payments Of Debt $0.00 $1.05M $93.63M $49.14M $0.00
Net Common Stock Issuance $0.00 $62.77M $98.00M $91.66M $2,000.00
Proceeds from Stock Option Exercised $3.73M $20.50M $3.47M $87.60M $73.29M
Net Other Financing Charges -$607,000.00 -$1.20M -$1.31M – –
Ending Cash Balance $370.08M $440.90M $434.35M $327.33M $327.33M
Net Change in Cash -$70.74M $7.31M $106.35M $147.05M $36.76M
Beginning Cash Balance $440.90M $434.35M $327.33M $180.29M $290.58M
Effect of Exchange Rate Changes -$86,000.00 -$763,000.00 $666,000.00 -$2,000.00 -$2,000.00
Free Cash Flow -$81.91M -$70.31M -$82.17M -$300.64M -$75.53M

Discussion

No comments yet — be the first to weigh in on SRRK.

Sign in to join the discussion.

Scroll to Top